AMT Medical Secures $25 Million in Series B Funding to Revolutionize Coronary Artery Bypass Surgery – [Cloned #5239]
Pioneering sutureless coronary bypass technology poised to eliminate open-chest procedures Sutureless anastomosis: Laser-assisted vessel connection via proprietary clipBeating-heart compatibility: Reduces stroke risks and complications, and potentially over 50% costreduction with a standardized, reproducible and easy-to-learn technology. EDE/UTRECHT, The Netherlands – April 17, 2025 – AMT Medical B.V., a clinical-stage medtech innovator, today announced a $25 million […]
Geert van Gansewinkel Joins AMT Medical as CEO
EDE/UTRECHT, The Netherlands – February 17, 2026 – AMT Medical, a pioneering medical technology company developing a next-generation minimally invasive coronary bypass platform, today announced the appointment of Geert van Gansewinkel as Chief Executive Officer, effective immediately. The leadership transition positions the company for its next phase of development of its ELANA® Heart Bypass System, […]
AMT Medical Secures $25 Million in Series B Funding to Revolutionize Coronary Artery Bypass Surgery
Pioneering sutureless coronary bypass technology poised to eliminate open-chest procedures Sutureless anastomosis: Laser-assisted vessel connection via proprietary clipBeating-heart compatibility: Reduces stroke risks and complications, and potentially over 50% costreduction with a standardized, reproducible and easy-to-learn technology. EDE/UTRECHT, The Netherlands – April 17, 2025 – AMT Medical B.V., a clinical-stage medtech innovator, today announced a $25 million […]
